Surface proteins are a key source of biomarkers and therapeutic targets, but remain poorly characterized in disease-relevant cells. Here, authors developed nanoMAPS, an ultrasensitive proteomic method to profile surface proteins from hundreds of primary cells and identify potential biomarkers.